Market News & Trends
Next-Generation Silicone Adhesive Technologies Key to Broader Global Adoption, Growth of Wearable Medical Devices
According to Grand View Research, the global market for wearable medical devices is expected to reach $27.8 billion by 2022.1 Dow Corning, a global leader…
Gemphire Announces Interim LDL-C Lowering Data From Clinical Trial
Gemphire Therapeutics Inc. recently announced interim data on the LDL-C primary endpoint from the ongoing open label COBALT-1 trial. COBALT-1 is investigating gemcabene in homozygous familial…
First Clinical Milestone Achieved in Collaboration Between AbCheck & Lilly
AbCheck s.r.o., a technology company focusing on the discovery and optimization of high-quality human antibodies, recently announced the achievement of the first clinical milestone in…
Abeona Therapeutics Enrolls First High-Dose Subject in Ongoing Phase I/II Trial
Abeona Therapeutics Inc. recently announced that the first high-dose subject was enrolled in the ongoing Phase I/II trial for ABO-102 (AAV-SGSH). The first-in-man clinical trial…
Advaxis’ GOG-0265 Study in Metastatic Cervical Cancer Selected for Late-Breaking Data Presentation
Advaxis, Inc. recently announced that an abstract on data from the company’s Phase II GOG-0265 trial evaluating axalimogene filolisbac for metastatic cervical cancer has been…
Gerresheimer Optimizes Cold-End Operations at its Pharma Glass Production Plants With State-of-the-Art Packing Robots
Every year, Gerresheimer’s pharmaceutical industry customers order several hundreds of millions of glass pharmaceutical packaging products manufactured at the company’s plants in Essen and Lohr.…
Incyte & Calithera Biosciences Announce Global Collaboration
Incyte Corporation and Calithera Biosciences, Inc. recently announced the companies have entered into a global collaboration and license agreement for the research, development, and commercialization…
Patheon Announces Completion of its Acquisition of State-of-the-Art Manufacturing Site
Patheon N.V (NYSE: PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced that it has completed…
SiO2 Medical Products, Inc. Receives Marketing Authorization for Filled 6-mL Vials
SiO2 Medical Products, Inc. (SMP) received marketing authorization (MA) for the Type II variation of the primary packaging of zoledronic acid from the German Medicines…
Patheon Announces Completion of its Acquisition of State-of-the-Art Manufacturing Site
Patheon N.V (NYSE: PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced that it has completed…
SiO2 Medical Products, Inc. Receives Marketing Authorization for Filled 6-mL Vials
SiO2 Medical Products, Inc. (SMP) received marketing authorization (MA) for the Type II variation of the primary packaging of zoledronic acid from the German Medicines…
West Introduces LyoSeal® Instant Sealing Solution & NovaGuard® SA Pro Safety System
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, recently introduced two new offerings at Pharmapack Europe 2017. The LyoSeal…
West Introduces LyoSeal® Instant Sealing Solution & NovaGuard® SA Pro Safety System
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, recently introduced two new offerings at Pharmapack Europe 2017. The LyoSeal…
Ompi Presents its Integrated Needlestick Protection
Pharmapak Paris, February 1-2, 2017, Paris Expo, Porte de Versailles, Paris, France, Hall 4 Visit Ompi at Booth No. J5 & Balda at Booth No.…
Ompi Presents its Integrated Needlestick Protection
Pharmapak Paris, February 1-2, 2017, Paris Expo, Porte de Versailles, Paris, France, Hall 4 Visit Ompi at Booth No. J5 & Balda at Booth No.…
Vetter Starts Operations in its Center for Visual Inspection & Logistics
Vetter recently announced it has begun operations in its expanded Visual Inspection and Logics Center located in Ravensburg. The enlargement, in which the company invested…
TG Therapeutics Announces Orphan Drug Designation
TG Therapeutics, Inc. recently announced that the US FDA has granted orphan drug designation covering the combination of TG-1101 (ublituximab), the company's novel, glycoengineered anti-CD20…
scPharmaceuticals Announces Start of SUBQ-HF NHLBI Study
scPharmaceuticals, Inc. recently announced the start of the first phase of a study conducted by the Heart Failure Clinical Research Network (HFN). HFN is a…
Neovacs Reports First Positive Immunogenicity Results
Neovacs recently announced the recommendation of its Scientific Advisory Board to extend the development of IFN Kinoid to a new indication, Type 1 Diabetes, with…
Domain Therapeutics & Merck Enter License & Collaboration Agreement
Domain Therapeutics recently announced that a collaboration and licensing agreement with Merck has been signed for the development of adenosine receptor antagonist drugs specifically designed…
